A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good news here too. Alzheimer's disease is a common cause of dementia.

The test is used to evaluate early signs of dementia (the progressive loss of intellectual functioning, especially memory and abstract thinking) in older adults. A score of 26 or more on the 30-point ...

BXCL501 is under investigation by BioXcel Therapeutics for the acute treatment of agitation associated with Alzheimer’s dementia and for the acute treatment of agitation associated with bipolar ...

Funded by a near $1 million MRFF Dementia, Ageing and Aged Care Mission Grant, the new study will equip pharmacists, nurses, and aged care workers with the tools to identify medication issues ...

Daughter Rumer Willis shared that her father is "doing great," bringing comfort to fans concerned about his battle with frontotemporal dementia. Since his diagnosis in 2022, fans have remained hopeful ...

Axsome's AXS-05 shows strong efficacy in treating Alzheimer's Disease Agitation, with significant CMAI score reductions in multiple Phase 3 trials. The FDA has greenlit Axsome to submit an sNDA ...

IGC Pharma has added HHS in Canada as a new clinical site for its Phase II CALMA trial of IGC-AD1 to treat agitation in ...

Sundowning is a phenomenon commonly experienced by those with dementia. As the day progresses into evening, symptoms such as confusion, agitation and restlessness can intensify. This can be ...

“This study highlights how movement-based interventions, like adapted dance, can be a meaningful way to improve both physical and emotional well-being for individuals with dementia ...